» Articles » PMID: 18177464

Myelin Abnormalities Without Oligodendrocyte Loss in Periventricular Leukomalacia

Overview
Journal Brain Pathol
Date 2008 Jan 8
PMID 18177464
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

The cellular basis of myelin deficits detected by neuroimaging in long-term survivors of periventricular leukomalacia (PVL) is poorly understood. We tested the hypothesis that oligodendrocyte lineage (OL) cell density is reduced in PVL, thereby contributing to subsequent myelin deficits. Using computer-based methods, we determined OL cell density in sections from 18 PVL and 18 age-adjusted control cases, immunostained with the OL-lineage marker Olig2. Myelination was assessed with myelin basic protein (MBP) immunostaining. We found no significant difference between PVL and control cases in Olig2 cell density in the periventricular or intragyral white matter. We did find, however, a significant increase in Olig2 cell density at the necrotic foci, compared with distant areas. Although no significant difference was found in the degree of MBP immunostaining, we observed qualitative abnormalities of MBP immunostaining in both the diffuse and necrotic components of PVL. Abnormal MBP immunostaining in PVL despite preserved Olig2 cell density may be secondary to arrested OL maturation, damage to OL processes, and/or impaired axonal-OL signaling. OL migration toward the "core" of injury may occur to replenish OL cell number. This study provides new insight into the cellular basis of the myelin deficits observed in survivors of PVL.

Citing Articles

Chronic Inflammation Offers Hints About Viable Therapeutic Targets for Preeclampsia and Potentially Related Offspring Sequelae.

Prasad J, Steenwinckel J, Gunn A, Bennet L, Korzeniewski S, Gressens P Int J Mol Sci. 2024; 25(23.

PMID: 39684715 PMC: 11640791. DOI: 10.3390/ijms252312999.


White matter protection with insulin-like growth factor-1 after hypoxia-ischaemia in preterm foetal sheep.

Wassink G, Cho K, Mathai S, Lear C, Dean J, Gunn A Brain Commun. 2024; 6(6):fcae373.

PMID: 39507274 PMC: 11539755. DOI: 10.1093/braincomms/fcae373.


Genetic investigations in cerebral palsy.

Basu A, Low K, Ratnaike T, Rowitch D Dev Med Child Neurol. 2024; 67(2):177-185.

PMID: 39208295 PMC: 11695794. DOI: 10.1111/dmcn.16080.


Role of Microglial Modulation in Therapies for Perinatal Brain Injuries Leading to Neurodevelopmental Disorders.

Fleiss B, Gressens P Adv Neurobiol. 2024; 37:591-606.

PMID: 39207715 DOI: 10.1007/978-3-031-55529-9_33.


Minimum effective dose of clemastine in a mouse model of preterm white matter injury.

Odell E, Jabassini N, Schniedewind B, Pease-Raissi S, Frymoyer A, Christians U Pediatr Res. 2024; 96(4):933-941.

PMID: 38942888 PMC: 11502491. DOI: 10.1038/s41390-024-03326-w.


References
1.
Pedraza L, Fidler L, Staugaitis S, Colman D . The active transport of myelin basic protein into the nucleus suggests a regulatory role in myelination. Neuron. 1997; 18(4):579-89. DOI: 10.1016/s0896-6273(00)80299-8. View

2.
Mandai K, Matsumoto M, Kitagawa K, Matsushita K, Ohtsuki T, Mabuchi T . Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience. 1997; 77(3):849-61. View

3.
Newcombe J, Eriksson B, Ottervald J, Yang Y, Franzen B . Extraction and proteomic analysis of proteins from normal and multiple sclerosis postmortem brain. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 815(1-2):191-202. DOI: 10.1016/j.jchromb.2004.10.073. View

4.
Inder T, Warfield S, Wang H, Huppi P, Volpe J . Abnormal cerebral structure is present at term in premature infants. Pediatrics. 2005; 115(2):286-94. DOI: 10.1542/peds.2004-0326. View

5.
Back S, Luo N, Mallinson R, OMalley J, Wallen L, Frei B . Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol. 2005; 58(1):108-20. DOI: 10.1002/ana.20530. View